JYNT - The Joint Corporation Market Capitalization-to-Revenue Ratio

Symbol and logo of brand The Joint Corporation (JYNT)

Steady demand for medical products guarantees the stability of The Joint Corp. (JYNT), which is confirmed by the calculated P/S on GURU.Markets, where the latest value is recorded as 1.60. A scalable franchise and licensing complexities for competitors create a defensive barrier. Dominance in the affordable spinal therapy niche, achieved by bypassing insurance, ensures the company maintains confident market share growth.

JYNT - The Joint Corporation Price-to-Revenue Ratio over the range 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for The Joint Corporation (JYNT)

- current quotes and average value forecast:
Summary company analytics:thejoint.com
Core merchandise of thejoint.com

High patient loyalty across The Joint Corp. (JYNT) manual therapy networks ensures a stable cash flow, which is visualized through the price-to-sales multiple. This indicator compares current market capitalization with the volume of generated revenue, allowing investors to determine the asset's degree of overvaluation relative to actual operating income and assess the efficiency of brand monetization over time.

Who The Joint Corp. competes with

HCA - Price to Sales|Tenet Healthcare Corporation - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio FMS|SOLV - Price-to-Revenue Ratio|Encompass - Market Cap to Sales Volume|uhsinc.com (UHS) - Price-to-Revenue Ratio|Price to Sales davita.com (DVA)|RDNT (RadNet) - P/S Multiple|Option Care (OPCH) - Price-to-Revenue Coefficient|Price-to-Revenue Ratio Surgery Partners Corp (SGRY)|Premier Health - Market Cap to Revenue Ratio|National Vision Holdings - Market Cap to Revenue|Market Cap to Sales Volume PGNY (progyny.com)|ARDT: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio SEM (Select Medical Corporation)|ASTH: P/S Multiple|Market Cap to Revenue MEDNAX|Price-to-Revenue Ratio US Physical Therapy|Price to Sales pennantgroup.com PNTG|Price-to-Revenue Ratio Organogenesis (ORGO)|NUTX (Nutex Health Inc) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Auna Health AUNA|SBC (SBC Medical Group Holdings) - Price-to-Sales Ratio|EOLS: Market Cap to Revenue|Price-to-Revenue Coefficient chs.net CYH|beautyhealth.com (SKIN) - Price-to-Revenue Ratio|MDWD: Market Cap to Sales Volume|Market Cap to Revenue BTMD|Price to Sales DocGo, Inc DCGO|Price-to-Revenue Ratio P3 Health Partners Inc. (PIII)|gaintherapeutics.com - Market Cap to Revenue Ratio|EUDA Health Holdings Limited - Market Cap to Revenue|Market Cap to Sales Volume BMGL (Basel Medical)|CLGN: Market Cap to Revenue|Cuprina Holdings Limited - Market Cap to Sales Volume|Concord Medical Services (CCM) - Price-to-Revenue Ratio|ashs.com - Market Capitalization-to-Revenue Ratio|MRM (MEDIROM Healthcare Group) - P/S Multiple|Price to Sales Avalon GloboCare Corporation ALBT|P/S Multiple DHAI|P/S Multiple Carmell Corp (XAGE)|NewGenIvf Group Limited - Market Cap to Revenue|Market Cap to Sales Volume ATIP (ATI Physical Therapy Inc.)|CMAX - Price-to-Revenue Ratio|Kindly MD Inc (KDLY) - Market Cap to Revenue|MODV: P/S Multiple|Price to Sales Novo Integrated Sciences Corp (NVOS)|Price-to-Revenue Ratio SunLink Health Systems Inc.|Market Cap to Revenue Ratio BACK (imacholdings.comm)